mr058666-web

Merck KGaA commits to continued partnership with Ugandan Government

September 5, 2017
Manufacturing and Production, Medical Communications Merck, infertility, life sciences, pharma, pharmaceuticals, uganda

Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit …

pfizer-building-logo1web

Pfizer’s drug back on the market after proving safety

September 5, 2017
Manufacturing and Production, Sales and Marketing Mylotarg, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …

novartis_side_building

Novartis celebrates success of Gilenya in paediatric multiple sclerosis

September 5, 2017
Manufacturing and Production, Research and Development MS, Novartis, gilenya, health, multiple sclerosis, pharma, pharmaceuticals

Novartis has announced results of its Phase 3 study investigating the safety and efficacy of Gilenya (fingolimod) , finding that …

merck_kgaa_pyramid_use_with_credit

Merck KGaA to streamline business with $1bn healthcare sale

September 5, 2017
Manufacturing and Production, Sales and Marketing GSK, Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business …

asthma

Asthma drugs reduce Parkinson’s risk by 50%, decade-long study finds

September 5, 2017
Manufacturing and Production, Research and Development Parkinson's, Parkinson's disease, asthma, pharma, pharmaceuticals, salbutamol

A study from the Department of Global Public Health and Primary Care at the University of Bergen (UiB) in Norway …

nhs_trees_brett_wells_source_web

NHS needs emergency £350 million to survive winter

September 4, 2017
Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

NHS Providers has stated that £350 million needs to be injected into the NHS to avoid the ‘humanitarian crisis’ that …

entrance_takeda_i020_v1

Takeda partners up to develop “next generation” CAR T solid tumour therapy

September 4, 2017
Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, Noile-Immune, Takeda, pharma, pharmaceuticals

Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …

Sanofi backs out of controversial Zika vaccine project

September 4, 2017
Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical

Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …

joseph_jimenez

Novartis CEO Jimenez announces retirement in 2018

September 4, 2017
Sales and Marketing Novartis, Vasant Narasimhan, joe jimenez, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez (pictured), is set to retire next year. In his place, Vasant …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

R&D tax credits: A novel approach to supply chain funding

September 1, 2017
Manufacturing and Production, Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, tax credits

Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …

astrazeneca_building_white

NICE rejects AstraZeneca’s breast cancer drug Faslodex

September 1, 2017
Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical

NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …

NHS pumps £100m into GP recruitment as numbers plummet

September 1, 2017
Medical Communications GP, NHS, biotech, drugs, pharma, pharmaceutical

The NHS has been forced to offer £100 million to recruitment agencies in order to plug growing gaps in the …

genentechlr

FDA approves treatment to counter CAR-T side-effects

August 31, 2017
Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …

lilly2_web

Lilly gets second shot at application for ‘blockbuster’ arthritis drug

August 31, 2017
Sales and Marketing Eli Lilly, arthritis, baricitinib, biotech, drugs, pharma, pharmaceutical

Earlier this year, Eli Lilly was on the receiving end of one of the most surprising setbacks in recent times …

teva

Teva scores expanded indication for Austedo in tardive dyskinesia

August 31, 2017
Sales and Marketing FDA, Teva, medicine, pharma, pharmaceuticals

Following the FDA’s approval of Teva’s Austedo (deutetrabenazine) in the treatment of chorea associated with Huntington’s disease in April this …

The Gateway to Local Adoption Series

Latest content